Filtered By:
Specialty: Cancer & Oncology
Source: Bulletin du Cancer

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

Complementary and alternative medicine use in two French pediatric oncology centers: A common practice.
CONCLUSION: The prevalence of complementary and alternative medicines administration is high, even if scientific evidence is limited regarding the effects, mechanisms of action and security of CAM. Research is necessary to improve the communication and council quality to the family, optimize supportive cares and reinforce the pharmacovigilance. PMID: 30771881 [PubMed - as supplied by publisher]
Source: Bulletin du Cancer - February 13, 2019 Category: Cancer & Oncology Authors: Menut V, Seigneur E, Gras Leguen C, Orbach D, Thebaud E Tags: Bull Cancer Source Type: research

Prescription in oncology: Homeopathy or psychotherapies and nicotine substitutes?
PMID: 29935913 [PubMed - as supplied by publisher]
Source: Bulletin du Cancer - June 20, 2018 Category: Cancer & Oncology Authors: Braillon A, Taiebi F Tags: Bull Cancer Source Type: research

Homeopathy in cancer patients: What does the "best" evidence tell us?
Abstract Homeopathic medicines are used by many patients with cancer, usually alongside conventional treatment. A recent report by the European Academies' Science Advisory Council concluded that "that there are no robust and reproducible evidence that homeopathy is effective". This literature review aims to make the analysis of published controlled randomized trials involving homeopathic treatment in the field of oncology. PMID: 29486922 [PubMed - as supplied by publisher]
Source: Bulletin du Cancer - February 24, 2018 Category: Cancer & Oncology Authors: de Nonneville A, Gonçalves A Tags: Bull Cancer Source Type: research

A French survey on the resort of oral alternative complementary medicines used in children with cancer.
CONCLUSIONS: The use of oral CAM in this survey was common. For most parents, this use was effective and appreciated because they generated fewer side effects than conventional treatments. However, doctors were not systematically informed of this use. This is problematic because some CAM such as herbal supplements could potentially cause interactions with cancer treatments. More information about CAM is necessary in pediatric onco-hematology. PMID: 26387822 [PubMed - as supplied by publisher]
Source: Bulletin du Cancer - September 17, 2015 Category: Cancer & Oncology Authors: Philibert C, Hoegy D, Philippe M, Marec-Bérard P, Bleyzac N Tags: Bull Cancer Source Type: research